| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Clinical Investigations |
1 Department of Diagnostic and Interventional Radiology, University of Essen, Essen, Germany
2 Department of Nuclear Medicine, University of Essen, Essen, Germany
3 Department of Internal Medicine (Tumor Research), University of Essen, Essen, Germany
4 Institute for Statistical Analysis, University of Essen, Essen, Germany
This study was implemented to compare the value of PET, CT, and dual-modality PET/CT imaging for assessing gastrointestinal stromal tumor (GIST) response to imatinib therapy. Methods: Twenty patients with histologically proven GIST underwent 18F-FDG PET/CT imaging before and 1, 3, and 6 mo after the start of imatinib therapy. Separate PET and CT datasets, side-by-side PET and CT datasets, and fused PET/CT images were evaluated according to World Health Organization, Response Evaluation Criteria in Solid Tumors, and European Organisation for Research and Treatment of Cancer criteria for therapy response. Hounsfield units (HU) were assessed on CT images. A mean follow-up period of 381 ± 134 d served as the standard of reference. Results: The numbers of lesions detected in all patients were 135 with PET, 249 with CT, 279 on side-by-side evaluation, and 282 on fused PET/CT images. Tumor response was correctly characterized in 95% of patients after 1 mo and 100% after 3 and 6 mo with PET/CT. PET and CT images viewed side by side were correct in 90% of patients at 1 mo and 100% at 3 and 6 mo. PET accurately diagnosed tumor response in 85% of patients at 1 mo and 100% at 3 and 6 mo. CT was found to be accurate in 44% of patients at 1 mo, 60% at 3 mo, and 57% at 6 mo. HU were found to decrease by at least 25% in 12 of 14 responders after 1 mo. Conclusion: Tumor response to imatinib should be assessed with a combination of morphologic and functional imaging. Image fusion with combined PET/CT can provide additional information in individual cases when compared with side-by-side PET and CT.
Key Words: gastrointestinal stromal tumor • imatinib • PET/CT
This article has been cited by other articles:
|
|
 |
|
  A. D. Van den Abbeele The Lessons of GIST--PET and PET/CT: A New Paradigm for Imaging Oncologist, April 1, 2008; 13(suppl_2): 8 - 13. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. H. Holdsworth, R. D. Badawi, J. B. Manola, M. F. Kijewski, D. A. Israel, G. D. Demetri, and A. D. Van den Abbeele CT and PET: Early Prognostic Indicators of Response to Imatinib Mesylate in Patients with Gastrointestinal Stromal Tumor Am. J. Roentgenol., December 1, 2007; 189(6): W324 - W330. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. A. Margolis, J. M. Hoffman, R. J. Herfkens, R. B. Jeffrey, A. Quon, and S. S. Gambhir Molecular Imaging Techniques in Body Imaging Radiology, November 1, 2007; 245(2): 333 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Herbst, A. M. Davies, R. B. Natale, T. P. Dang, J. H. Schiller, L. L. Garland, V. A. Miller, D. Mendelson, A. D. Van den Abbeele, Y. Melenevsky, et al. Efficacy and Safety of Single-Agent Pertuzumab, a Human Epidermal Receptor Dimerization Inhibitor, in Patients with Non Small Cell Lung Cancer Clin. Cancer Res., October 15, 2007; 13(20): 6175 - 6181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Desai, S. Shankar, M. C. Heinrich, J. A. Fletcher, C. D. Fletcher, J. Manola, J. A. Morgan, C. L. Corless, S. George, K. Tuncali, et al. Clonal Evolution of Resistance to Imatinib in Patients with Metastatic Gastrointestinal Stromal Tumors Clin. Cancer Res., September 15, 2007; 13(18): 5398 - 5405. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Choi, C. Charnsangavej, S. C. Faria, H. A. Macapinlac, M. A. Burgess, S. R. Patel, L. L. Chen, D. A. Podoloff, and R. S. Benjamin Correlation of Computed Tomography and Positron Emission Tomography in Patients With Metastatic Gastrointestinal Stromal Tumor Treated at a Single Institution With Imatinib Mesylate: Proposal of New Computed Tomography Response Criteria J. Clin. Oncol., May 1, 2007; 25(13): 1753 - 1759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Benjamin, H. Choi, H. A. Macapinlac, M. A. Burgess, S. R. Patel, L. L. Chen, D. A. Podoloff, and C. Charnsangavej We Should Desist Using RECIST, at Least in GIST J. Clin. Oncol., May 1, 2007; 25(13): 1760 - 1764. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Q.M. Chow and S. G. Eckhardt Sunitinib: From Rational Design to Clinical Efficacy J. Clin. Oncol., March 1, 2007; 25(7): 884 - 896. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. A. Weber and R. Figlin Monitoring Cancer Treatment with PET/CT: Does It Make a Difference? J. Nucl. Med., January 1, 2007; 48(1_suppl): 36S - 44S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kuehl, P. Veit, S. J. Rosenbaum, A. Bockisch, and G. Antoch Can PET/CT Replace Separate Diagnostic CT for Cancer Imaging? Optimizing CT Protocols for Imaging Cancers of the Chest and Abdomen J. Nucl. Med., January 1, 2007; 48(1_suppl): 45S - 57S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Czernin, M. Allen-Auerbach, and H. R. Schelbert Improvements in Cancer Staging with PET/CT: Literature-Based Evidence as of September 2006 J. Nucl. Med., January 1, 2007; 48(1_suppl): 78S - 88S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. B. Prabhakar, D. V. Sahani, A. J. Fischman, P. R. Mueller, and M. A. Blake Bowel Hot Spots at PET-CT RadioGraphics, January 1, 2007; 27(1): 145 - 159. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Lassau, M. Lamuraglia, L. Chami, J. Leclere, S. Bonvalot, P. Terrier, A. Roche, and A. Le Cesne Gastrointestinal stromal tumors treated with imatinib: monitoring response with contrast-enhanced sonography. Am. J. Roentgenol., November 1, 2006; 187(5): 1267 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K M Linton, M B Taylor, and J A Radford Response evaluation in gastrointestinal stromal tumours treated with imatinib: misdiagnosis of disease progression on CT due to cystic change in liver metastases Br. J. Radiol., August 1, 2006; 79(944): e40 - e44. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Weber Positron Emission Tomography As an Imaging Biomarker J. Clin. Oncol., July 10, 2006; 24(20): 3282 - 3292. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Meyer, S. Aliberti, G. Grignani, M. Aglietta, M. E. Juweid, and B. D. Cheson Positron-emission tomography in cancer therapy. N. Engl. J. Med., May 4, 2006; 354(18): 1958 - 1960. [Full Text] [PDF]
|
|
|
|
|
|
X. Hong, H. Choi, E. M. Loyer, R. S. Benjamin, J. C. Trent, and C. Charnsangavej Gastrointestinal Stromal Tumor: Role of CT in Diagnosis and in Response Evaluation and Surveillance after Treatment with Imatinib. RadioGraphics, March 1, 2006; 26(2): 481 - 495. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. R. Warakaulle and F. Gleeson MDCT Appearance of Gastrointestinal Stromal Tumors After Therapy with Imatinib Mesylate Am. J. Roentgenol., February 1, 2006; 186(2): 510 - 515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. K. von Schulthess, H. C. Steinert, and T. F. Hany Integrated PET/CT: Current Applications and Future Directions Radiology, February 1, 2006; 238(2): 405 - 422. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. S. Benjamin, C. D. Blanke, J.-Y. Blay, S. Bonvalot, and B. Eisenberg Management of Gastrointestinal Stromal Tumors in the Imatinib Era: Selected Case Studies Oncologist, January 1, 2006; 11(1): 9 - 20. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. A. Weber Use of PET for Monitoring Cancer Therapy and for Predicting Outcome J. Nucl. Med., June 1, 2005; 46(6): 983 - 995. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Blodgett, B. Casagranda, D. W. Townsend, and C. C. Meltzer Issues, Controversies, and Clinical Utility of Combined PET/CT Imaging: What Is the Interpreting Physician Facing? Am. J. Roentgenol., May 1, 2005; 184(5_supp): S138 - S145. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. J. Kelloff, J. M. Hoffman, B. Johnson, H. I. Scher, B. A. Siegel, E. Y. Cheng, B. D. Cheson, J. O'Shaughnessy, K. Z. Guyton, D. A. Mankoff, et al. Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development Clin. Cancer Res., April 15, 2005; 11(8): 2785 - 2808. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-Y. Blay, S. Bonvalot, P. Casali, H. Choi, M. Debiec-Richter, A. P. Dei Tos, J.-F. Emile, A. Gronchi, P. C. W. Hogendoorn, H. Joensuu, et al. Consensus meeting for the management of gastrointestinal stromal tumors * Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO Ann. Onc., April 1, 2005; 16(4): 566 - 578. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |
